Group sequential, sample size re‐estimation and two‐stage adaptive designs in clinical trials: a comparison
- 11 October 2005
- journal article
- editorial
- Published by Wiley in Statistics in Medicine
- Vol. 25 (6) , 933-941
- https://doi.org/10.1002/sim.2252
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Two‐stage adaptive strategy for superiority and non‐inferiority hypotheses in active controlled clinical trialsStatistics in Medicine, 2004
- On the inefficiency of the adaptive design for monitoring clinical trialsBiometrika, 2003
- Sample Size Reestimation for Clinical Trials With Censored Survival DataJournal of the American Statistical Association, 2003
- Controlling type I error rate for fast track drug development programmesStatistics in Medicine, 2003
- A sample size adjustment procedure for clinical trials based on conditional powerBiostatistics, 2002
- Group sequential test strategies for superiority and non‐inferiority hypotheses in active controlled clinical trialsStatistics in Medicine, 2001
- Sample size re-estimation without unblinding for normally distributed outcomes with unknown varianceCommunications in Statistics - Theory and Methods, 1992
- The role of internal pilot studies in increasing the efficiency of clinical trialsStatistics in Medicine, 1990
- The preliminary report of the findings of the aspirin component of the ongoing Physicians' Health Study. The FDA perspective on aspirin for the primary prevention of myocardial infarctionPublished by American Medical Association (AMA) ,1988